Telesis Bio (TBIO) Stock Chart & Stock Price History → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free TBIO Stock Alerts $4.35 -0.27 (-5.84%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Telesis Bio Stock Price Performance5 Day Performance-15.04%1 Month Performance-34.24%3 Month Performance-23.50%6 Month Performance-46.30%Year-To-Date Performance-39.43%1 Year Performance-87.98% Receive TBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 TBIO Stock Chart for Thursday, May, 16, 2024 TBIO Chart by TradingView Telesis Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$4.62$4.35-5.90%$4.63$4.3116,314 shs$7.31 million05/15/2024$4.22$4.62+9.67%$4.69$4.1682,353 shs$7.77 million05/14/2024$4.15$4.22+1.57%$4.45$3.9656,657 shs$7.04 million05/13/2024$5.12$4.15-18.95%$4.53$4.0282,630 shs$6.93 million05/10/2024$6.01$5.12-14.81%$5.70$5.0480,967 shs$154.13 million05/09/2024$5.74$6.01+4.67%$6.40$4.90259,860 shs$180.90 million Get the Latest News and Ratings for TBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$5.51$5.74+4.25%$7.29$5.4073,709 shs$9.60 million05/07/2024$6.12$5.51-9.97%$5.76$5.0444,891 shs$9.21 million05/06/2024$5.94$6.12+3.00%$6.12$5.771,228 shs$10.23 million05/03/2024$6.38$5.94-6.83%$6.46$5.698,075 shs$9.93 million05/02/2024$6.40$6.38-0.42%$6.48$5.791,079 shs$10.66 million05/01/2024$6.50$6.40-1.47%$6.48$5.597,906 shs$10.71 million04/30/2024$6.11$6.50+6.33%$6.84$6.129,073 shs$10.87 million04/29/2024$5.73$6.11+6.63%$6.30$5.941,390 shs$10.22 million04/26/2024$5.96$5.73-3.89%$5.73$5.541,457 shs$9.58 million04/25/2024$5.78$5.96+3.11%$6.12$5.621,310 shs$9.97 million04/24/2024$5.75$5.78+0.53%$6.30$5.427,094 shs$9.67 million04/23/2024$5.67$5.75+1.40%$6.10$5.587,729 shs$9.62 million04/22/2024$5.56$5.67+2.01%$6.01$5.393,846 shs$9.49 million04/19/2024$5.94$5.56-6.42%$6.30$5.408,987 shs$9.30 million04/18/2024$7.01$5.94-15.22%$7.92$5.6114,383 shs$9.94 million04/17/2024$6.62$7.01+5.99%$7.20$6.411,378 shs$11.72 million04/16/2024$6.80$6.62-2.70%$7.11$6.302,978 shs$11.06 million04/15/2024$7.38$6.80-7.88%$7.51$6.481,793 shs$11.37 million04/12/2024$7.91$7.38-6.67%$7.74$7.361,737 shs$12.34 million04/11/2024$7.68$7.91+3.00%$8.19$7.611,600 shs$13.22 million04/10/2024$7.74$7.68-0.84%$8.17$7.681,335 shs$12.84 million04/09/2024$7.75$7.74-0.14%$8.32$7.602,108 shs$12.95 million04/08/2024$7.92$7.75-2.11%$8.32$7.61829 shs$12.96 million04/05/2024$8.30$7.92-4.56%$8.42$7.921,040 shs$13.24 million04/04/2024$8.59$8.30-3.35%$8.44$7.921,977 shs$13.88 million04/03/2024$7.89$8.59+8.78%$8.61$7.492,102 shs$14.36 million04/02/2024$7.84$7.89+0.67%$8.06$7.741,286 shs$13.15 million04/01/2024$7.92$7.84-1.00%$8.25$7.453,641 shs$13.06 million03/29/2024$7.92$7.92$8.10$7.792,367 shs$13.19 million03/28/2024$8.10$7.92-2.22%$8.10$7.791,638 shs$13.19 million03/27/2024$7.88$8.10+2.74%$8.10$7.714,384 shs$13.49 million03/26/2024$8.10$7.88-2.67%$8.53$7.673,029 shs$13.13 million03/25/2024$8.01$8.10+1.12%$8.82$7.673,936 shs$13.49 million03/22/2024$8.62$8.01-7.10%$8.82$7.562,819 shs$13.34 millionWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 202403/21/2024$8.15$8.62+5.74%$8.64$7.026,601 shs$14.36 million03/20/2024$9.70$8.15-15.96%$9.60$6.4823,639 shs$13.58 million03/19/2024$9.72$9.70-0.19%$9.94$9.052,120 shs$16.16 million03/18/2024$9.34$9.72+4.05%$10.06$9.014,167 shs$16.19 million03/15/2024$9.26$9.34+0.93%$9.47$8.376,367 shs$15.56 million03/14/2024$9.78$9.26-5.36%$10.17$9.043,672 shs$15.42 million03/13/2024$9.77$9.78+0.06%$10.42$9.723,351 shs$16.29 million03/12/2024$9.58$9.77+2.07%$10.62$9.428,237 shs$16.28 million03/11/2024$9.88$9.58-3.10%$10.15$9.424,061 shs$15.95 million03/08/2024$9.18$9.88+7.65%$10.08$9.248,583 shs$16.46 million03/07/2024$8.82$9.18+4.08%$9.38$8.514,124 shs$15.29 million03/06/2024$9.32$8.82-5.41%$9.45$8.7510,849 shs$14.69 million03/05/2024$8.68$9.32+7.45%$9.36$8.4617,614 shs$15.53 million03/04/2024$9.52$8.68-8.83%$9.45$8.4612,421 shs$14.45 million03/01/2024$10.05$9.52-5.32%$10.22$9.158,494 shs$15.85 million02/29/2024$10.08$10.05-0.23%$10.06$8.1019,313 shs$16.74 million02/28/2024$10.39$10.08-3.03%$10.08$9.1831,757 shs$16.78 million02/27/2024$11.88$10.39-12.53%$10.94$9.0240,566 shs$17.31 million02/26/2024$14.04$11.88-15.38%$13.66$10.8071,299 shs$19.79 million02/23/2024$8.25$14.04+70.27%$15.46$8.251.19 million shs$23.38 million02/22/2024$6.34$8.25+30.14%$8.46$5.80462,156 shs$13.73 million02/21/2024$5.74$6.34+10.34%$6.66$5.609,386 shs$10.55 million02/20/2024$5.69$5.74+0.98%$5.86$5.582,048 shs$9.56 million02/19/2024$5.69$5.69$5.89$5.584,739 shs$9.47 million02/16/2024$5.59$5.69+1.80%$5.89$5.584,740 shs$9.47 million02/15/2024$5.92$5.59-5.68%$5.94$5.583,183 shs$9.30 million Related Companies: Precipio Stock Chart Talis Biomedical Stock Chart Accelerate Diagnostics Stock Chart Cue Health Stock Chart Singular Genomics Systems Stock Chart Rapid Micro Biosystems Stock Chart Biomerica Stock Chart BioRestorative Therapies Stock Chart Organovo Stock Chart Addex Therapeutics Stock Chart Receive TBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBIO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHow Biden has already won 2024Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsAmericans Now Need $1.46M to Retire…Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.